Prolactin "minitherapy" with SMI-1 (novel protocol for lowering prolactin locally)

Dimitri001

Experienced Member
My Regimen
Reaction score
343
IDK anything about this, but it's possible that "modest cytotoxicity" of 10 μM is something that's negligible, of course it could also mean that it shouldn't be used under any circumstances, IDK, but I guess that it's moot since we can just use SMI-6.

Is there a difference in binding affinity between SMI 6 and 1?
 

uzzzzzzzi

New Member
My Regimen
Reaction score
9
Will AR monoclonal antibody work? Jsut like Bayer's PRLR monoclonal antibody.

THere are many AR monoclonal antibody we could buy.
 

Throwaway94

Experienced Member
My Regimen
Reaction score
615
There's been so much trolling lately that I have to ask, is this legit?

Results indicated SMI 1 and 6 had minimal toxicity, ensuring both molecules' capabilities to be therapeutic agents.
Here you are champs this was from their follow up study:
Screenshot_2021-08-23-18-19-57-843_com.adobe.reader.jpg
 

Dimitri001

Experienced Member
My Regimen
Reaction score
343
Will AR monoclonal antibody work? Jsut like Bayer's PRLR monoclonal antibody.

THere are many AR monoclonal antibody we could buy.
I suppose it could, but it wouldn't give you regrowth (or not much), whereas blocking the PRLR SHOULD, if the monkey results translate. Furthermore, what would the sides be? If some ppl get gyno and impotence from finasteride, what would the rate of sides be if you blocked every AR in your body (assuming it would also be administered non-locally).
 

RolfLeeBuckler

Experienced Member
My Regimen
Reaction score
985
I suppose it could, but it wouldn't give you regrowth (or not much), whereas blocking the PRLR SHOULD, if the monkey results translate. Furthermore, what would the sides be? If some ppl get gyno and impotence from finasteride, what would the rate of sides be if you blocked every AR in your body (assuming it would also be administered non-locally).
they did Phase I study of HMI-115 in human.
No side effects reported so it is free of sides
 

Chads don't bald

Established Member
My Regimen
Reaction score
107
they did Phase I study of HMI-115 in human.
No side effects reported so it is free of sides
He's talking about the AR antibody

Blocking all AR's in your body would be really bad for you. Finasteride is ok because it doesn't block AR's, it simply prevents 5-ar enzyme from converting T to DHT.
 

Dimitri001

Experienced Member
My Regimen
Reaction score
343
they did Phase I study of HMI-115 in human.
No side effects reported so it is free of sides
I thought there was no info published on phase I. Are you just assuming there were no sides because they moved ahead with phase II or was some info actually put out?
 

badhabiz

Experienced Member
My Regimen
Reaction score
220
It only inhibits prolactin from the pituitary gland and has no effect on hair.
not only
causes hair loss, like all dopaminergics




this smi-6 uses a diff path tho, its fascinating
 

sicco

New Member
My Regimen
Reaction score
2
Hi,

I really don’t want to get dragged down into the weird drama of this forum but I am fascinated by this drug and would like to participate in the discord/group buy. Could someone DM me the discord link? Seems like that’s where all the good stuff is happening. Thank you!
 

Blisty

New Member
My Regimen
Reaction score
0
Hello

The same as Sicco, I would like to join the discord and participate in the next group buy. Can a member of the discord send me an invitation message? Thank you very much.
 

scientist_0005

Banned
My Regimen
Reaction score
122
I see a lot of people participating in these group buys and after digging a bit into the science of it especially the paper published on the stump tailed monkeys that are a good animal model for androgenic alopecia i can understand the temptation at least some of it. however, prolactin and its effect on hair has been studied before has it not? there are no major publications that remotely indicate that it could have such potential. for every compaound ever trialed, i can understand the pathway and how exactly it might be involved in the pathology of AA. however, with this antibody, i get it the monkey have AA too but still... what is the theory behind this? how does it fit into the conventinally believed model of AA? I am sure someone has thrown in some idea in those 33 pages of thread but i can not read through that. I read quite some papers and some have found a suppression of anagen phase but only when prolactin in very high levels was used. which means that for a normal ranged guy, suppressing any signaling even further, how much is that going to profit them? no research on that at all.

I really hope, hopemed is going to trial this drug for AA. so far, they have only announced a trial for the other condition and i am afraid, it could go down like it did with companies of the likes of beloved cassiopea who took a literal decade to achieve a literal pile of nothing and they decided acne was their place to be and so totally neglected AA. I have a feeling this could be very similar with hopemed. what are the similarities? the vagina disease hopemed is trying to cure would also be covered by insurance, very convenient when you have an anti body that would probably cost thosuands of dollars in a prescription. for cassipea, this horse was acne. but we will see, hopefully very soon too
 

RolfLeeBuckler

Experienced Member
My Regimen
Reaction score
985
I see a lot of people participating in these group buys and after digging a bit into the science of it especially the paper published on the stump tailed monkeys that are a good animal model for androgenic alopecia i can understand the temptation at least some of it. however, prolactin and its effect on hair has been studied before has it not? there are no major publications that remotely indicate that it could have such potential. for every compaound ever trialed, i can understand the pathway and how exactly it might be involved in the pathology of AA. however, with this antibody, i get it the monkey have AA too but still... what is the theory behind this? how does it fit into the conventinally believed model of AA? I am sure someone has thrown in some idea in those 33 pages of thread but i can not read through that. I read quite some papers and some have found a suppression of anagen phase but only when prolactin in very high levels was used. which means that for a normal ranged guy, suppressing any signaling even further, how much is that going to profit them? no research on that at all.

I really hope, hopemed is going to trial this drug for AA. so far, they have only announced a trial for the other condition and i am afraid, it could go down like it did with companies of the likes of beloved cassiopea who took a literal decade to achieve a literal pile of nothing and they decided acne was their place to be and so totally neglected AA. I have a feeling this could be very similar with hopemed. what are the similarities? the vagina disease hopemed is trying to cure would also be covered by insurance, very convenient when you have an anti body that would probably cost thosuands of dollars in a prescription. for cassipea, this horse was acne. but we will see, hopefully very soon too
How do you know the Phase II Trial of Hope med. planned For Q4 this year in US isnt the AA Trial?
 

scientist_0005

Banned
My Regimen
Reaction score
122

here you go @RolfLeeBuckler

"and most importantly a frontrunner asset HMI-115 that has got IND approval from the US FDA for Phase II clinical trial in endometriosis, and patient recruitment for the US Phase II clinical trial will start by Q4 of this year."

they have FDA approval for a clinical trial for the indication of "endometriosis". they do not have even FDA approval to conduct a trial in any other condition at this point in time.

just as i said, you do not develop such an expensive anti body for a condition that is not covered by insurance and while being underserved does really not have that much of a market potential. they will start clinical trial for the vagine condition soon. when will they start for AA? my guess is it will be the same as with Cassiopea where one product will be 5-6 years behind. now keep in mind that not every management is as aggressively incompetent as that shitty company from Italy but still, i would highly doubt that there will be a clinical phase 2 trial of this compound for the indication of AA before 2025. sad that hair loss is one again getting the short end of the stick but this is to be expected.


edit: the trial wont even start in Q4, recruitment will so add another 6 months on top of that time line. also multi center does not mean trial for multiple conditions, it just means in multiple institutes. really a bummer and i wish the drug would not work for the vagine disease
 
Last edited:
Top